| Dr Todd Ryan Grunander, MD | |
|
4403 Harrison Blvd, Suite 2400, Ogden, UT 84403-3271 | |
| (801) 387-2750 | |
| Not Available |
| Full Name | Dr Todd Ryan Grunander |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 18 Years |
| Location | 4403 Harrison Blvd, Ogden, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336396340 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 8005885-1205 (Utah) | Secondary |
| 207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | 8005885-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intermountain Homecare Ogden | Ogden, UT | Home health agency |
| Community Nursing Services | West valley city, UT | Home health agency |
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Davis Hospital And Medical Center | Layton, UT | Hospital |
| Layton Hospital | Layton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Biomedical researchers have identified a cellular protein that interferes with hepatitis C virus replication, a finding that ultimately may help scientists develop new drugs to fight the virus.
Systagenix announced on 20 April 2011 that a recent product evaluation published in the journal Wounds UK, Vol 7, No 1, demonstrates the clinical effectiveness of ADAPTIC TOUCH® as a primary wound contact layer that addresses the needs of both patients and healthcare professionals.
The South African National AIDS Council (SANAC) on Saturday endorsed a new National Health Council policy to expand the country's AIDS program "to allow people living with HIV to start antiretroviral [ARV] treatment earlier" by raising the CD4 count necessary to access treatment from 200 to 350, Agence France-Presse reports.
InteKrin Therapeutics Inc. announced today it will present 6 month Phase 2b clinical data for edema in diabetic patients showing differentiation for INT131, a Selective PPAR-gamma Modulator (SPPARM), from Actos® pioglitazone, at the American Diabetes Association annual meeting in Orlando, FL, Monday, June 28, 2010 at 2:45 pm EDT during the "Update on BARI 2D -Treatment of Insulin Resistance" session.
› Verified 5 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Biomedical researchers have identified a cellular protein that interferes with hepatitis C virus replication, a finding that ultimately may help scientists develop new drugs to fight the virus.
Systagenix announced on 20 April 2011 that a recent product evaluation published in the journal Wounds UK, Vol 7, No 1, demonstrates the clinical effectiveness of ADAPTIC TOUCH® as a primary wound contact layer that addresses the needs of both patients and healthcare professionals.
The South African National AIDS Council (SANAC) on Saturday endorsed a new National Health Council policy to expand the country's AIDS program "to allow people living with HIV to start antiretroviral [ARV] treatment earlier" by raising the CD4 count necessary to access treatment from 200 to 350, Agence France-Presse reports.
InteKrin Therapeutics Inc. announced today it will present 6 month Phase 2b clinical data for edema in diabetic patients showing differentiation for INT131, a Selective PPAR-gamma Modulator (SPPARM), from Actos® pioglitazone, at the American Diabetes Association annual meeting in Orlando, FL, Monday, June 28, 2010 at 2:45 pm EDT during the "Update on BARI 2D -Treatment of Insulin Resistance" session.
› Verified 5 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Biomedical researchers have identified a cellular protein that interferes with hepatitis C virus replication, a finding that ultimately may help scientists develop new drugs to fight the virus.
Systagenix announced on 20 April 2011 that a recent product evaluation published in the journal Wounds UK, Vol 7, No 1, demonstrates the clinical effectiveness of ADAPTIC TOUCH® as a primary wound contact layer that addresses the needs of both patients and healthcare professionals.
The South African National AIDS Council (SANAC) on Saturday endorsed a new National Health Council policy to expand the country's AIDS program "to allow people living with HIV to start antiretroviral [ARV] treatment earlier" by raising the CD4 count necessary to access treatment from 200 to 350, Agence France-Presse reports.
InteKrin Therapeutics Inc. announced today it will present 6 month Phase 2b clinical data for edema in diabetic patients showing differentiation for INT131, a Selective PPAR-gamma Modulator (SPPARM), from Actos® pioglitazone, at the American Diabetes Association annual meeting in Orlando, FL, Monday, June 28, 2010 at 2:45 pm EDT during the "Update on BARI 2D -Treatment of Insulin Resistance" session.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Todd Ryan Grunander, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 387-2750 | Dr Todd Ryan Grunander, MD 4403 Harrison Blvd, Suite 2400, Ogden, UT 84403-3271 Ph: (801) 387-2750 |
News Archive
Biomedical researchers have identified a cellular protein that interferes with hepatitis C virus replication, a finding that ultimately may help scientists develop new drugs to fight the virus.
Systagenix announced on 20 April 2011 that a recent product evaluation published in the journal Wounds UK, Vol 7, No 1, demonstrates the clinical effectiveness of ADAPTIC TOUCH® as a primary wound contact layer that addresses the needs of both patients and healthcare professionals.
The South African National AIDS Council (SANAC) on Saturday endorsed a new National Health Council policy to expand the country's AIDS program "to allow people living with HIV to start antiretroviral [ARV] treatment earlier" by raising the CD4 count necessary to access treatment from 200 to 350, Agence France-Presse reports.
InteKrin Therapeutics Inc. announced today it will present 6 month Phase 2b clinical data for edema in diabetic patients showing differentiation for INT131, a Selective PPAR-gamma Modulator (SPPARM), from Actos® pioglitazone, at the American Diabetes Association annual meeting in Orlando, FL, Monday, June 28, 2010 at 2:45 pm EDT during the "Update on BARI 2D -Treatment of Insulin Resistance" session.
› Verified 5 days ago
Dr. Casey C Bachison, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd, Suite 2400, Ogden, UT 84403 Phone: 801-387-2750 Fax: 801-387-2755 | |
Bruce E Thomas, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr, Suite 101, Ogden, UT 84403 Phone: 801-475-5683 Fax: 801-475-9499 | |
Brent M Baranko, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Harrison Blvd, Ogden, UT 84403 Phone: 801-475-3300 Fax: 801-475-3301 | |
Brett Evan Richards, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Harrison Blvd, Ogden, UT 84403 Phone: 801-475-3300 Fax: 801-475-3301 | |
Donald William Bryan, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4403 Harrison Blvd, Ste 2600, Ogden, UT 84403 Phone: 801-387-2600 Fax: 801-387-2625 | |
Damian Illing, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Harrison Blvd, Ogden, UT 84403 Phone: 801-475-3300 Fax: 801-475-3301 |